AOL Money & Finance

BENLYSTA posts

Feed

Closing Bell: After 9 in a row, can tech make a 10 day run? (CSCO, CIT, HAS, HGSI, LVS)

Today was a day saved by CIT Group, Inc. (NYSE: CIT). The stronger Leading Economic Indicators helped, but today was all about a less futile financial services sector. It was also the 9th day in a row that the NASDAQ was up on the day.

Here were the unofficial closing bell levels:

Dow 8,847.93 +103.99 (1.19%)
S&P 500 950.97 +10.59 (1.13%)
Nasdaq 1,909.29 +22.68 (1.20%)

Top Analyst Calls

Continue reading Closing Bell: After 9 in a row, can tech make a 10 day run? (CSCO, CIT, HAS, HGSI, LVS)

Options Update: Human Genome options expensive; shares up 215%

Human Genome (NASDAQ: HGSI) is recently trading at $11.07 in pre-open trading, above its close of $3.32. Human Genome Sciences and GlaxoSmithKline (NYSE: GSK) announced that BENLYSTA met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus. HGSI August 2.5 straddle is priced at $2.45, October 2.5 straddle is priced at $2.75, January 2.5 straddle is priced at $3.25 according to Track Data, suggesting large price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Symbol Lookup
IndexesChangePrice
DJIA-154.4810,309.92
NASDAQ-37.612,138.44
S&P 500-19.141,091.49

Last updated: November 28, 2009: 11:01 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance